Sibhghatulla Shaikh Selected Research

beta-lactamase CTX-M-15

11/2020

Dual-targeting potential of active constituents of Nigella sativa against FimH and CTX-M-15: A plausible therapeutic strategy against drug-resistant uropathogenic strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sibhghatulla Shaikh Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2014
5	Nervous System Diseases (Neurological Disorders) 06/2016 - 01/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021 - 01/2020
2	Infections 01/2021 - 01/2015
2	Neoplasms (Cancer) 01/2021 - 06/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2014 - 06/2013
1	Sarcopenia 07/2022
1	Muscular Atrophy (Muscle Atrophy) 07/2022
1	Cachexia 04/2022
1	Wasting Syndrome (Wasting Disease) 04/2022
1	Cognitive Dysfunction 07/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021
1	Atrophy 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Disease Progression 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 11/2020
1	Insulin Resistance 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Muscular Dystrophies (Muscular Dystrophy) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Bacterial Infections (Bacterial Infection) 05/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2014
1	Epilepsy (Aura) 01/2014
1	Major Depressive Disorder (Major Depressive Disorders) 01/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2014
3	MyostatinIBA 07/2022 - 04/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2014
3	Pharmaceutical PreparationsIBA 06/2016 - 01/2014
2	Biological ProductsIBA 07/2021 - 01/2021
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2019 - 01/2015
1	Activins (Activin)IBA 04/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	3-nitrotyrosineIBA 01/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2021
1	IntegrinsIBA 01/2021
1	beta-lactamase CTX-M-15IBA 11/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Laminin (Merosin)IBA 01/2020
1	Protein AggregatesIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	CollagenIBA 01/2020
1	Glyoxal (Ethanedial)IBA 01/2020
1	GoldIBA 01/2020
1	PlasticsIBA 01/2020
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2020
1	Disinfectants (Biocides)IBA 05/2019
1	ThiazolidinedionesIBA 06/2016
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 06/2016
1	glimepiride (Amarel)FDA LinkGeneric 06/2016
1	dapagliflozinIBA 01/2016
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2015
1	AcetylcholinesteraseIBA 04/2014
1	CanagliflozinIBA 04/2014
1	SymportersIBA 04/2014
1	Sodium-Glucose Transport ProteinsIBA 04/2014
1	SodiumIBA 04/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2014
1	Dimethoate (Rogor)IBA 01/2014
1	Voltage-Gated Sodium ChannelsIBA 01/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2014
1	Serotonin (5 Hydroxytryptamine)IBA 01/2014
1	LevomilnacipranIBA 01/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2014
1	GelatinasesIBA 01/2014
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2014
1	eslicarbazepine acetateIBA 01/2014
1	CarcinogensIBA 06/2013
1	DichlorvosIBA 06/2013

Therapy/Procedure

8	Therapeutics 04/2022 - 01/2014